These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 3385428
1. Immunocytochemical evidence for Semliki Forest virus antigen persistence in mouse brain. Khalili-Shirazi A, Gregson N, Webb HE. J Neurol Sci; 1988 May; 85(1):17-26. PubMed ID: 3385428 [Abstract] [Full Text] [Related]
2. Immunological relationship between a demyelinating RNA enveloped budding virus (Semliki Forest) and brain glycolipids. Khalili-Shirazi A, Gregson N, Webb HE. J Neurol Sci; 1986 Nov; 76(1):91-103. PubMed ID: 3783190 [Abstract] [Full Text] [Related]
3. Virulent and avirulent strains of Semliki Forest virus show similar cell tropism for the murine central nervous system but differ in the severity and rate of induction of cytolytic damage. Balluz IM, Glasgow GM, Killen HM, Mabruk MJ, Sheahan BJ, Atkins GJ. Neuropathol Appl Neurobiol; 1993 Jun; 19(3):233-9. PubMed ID: 8395026 [Abstract] [Full Text] [Related]
4. Multiplication of virulent and demyelinating Semliki Forest virus in the mouse central nervous system: consequences in BALB/c and SJL mice. Smyth JM, Sheahan BJ, Atkins GJ. J Gen Virol; 1990 Nov; 71 ( Pt 11)():2575-83. PubMed ID: 2174955 [Abstract] [Full Text] [Related]
5. Antigenic differences between virulent and avirulent strains of Semliki Forest viruses detected with monoclonal antibodies. Brief report. Boere WA, Harmsen M, Kraaijeveld CA, Snippe H. Arch Virol; 1986 Nov; 88(1-2):105-12. PubMed ID: 2420309 [Abstract] [Full Text] [Related]
6. The Semliki Forest virus E2 gene as a virulence determinant. Santagati MG, Määttä JA, Itäranta PV, Salmi AA, Hinkkanen AE. J Gen Virol; 1995 Jan; 76 ( Pt 1)():47-52. PubMed ID: 7844541 [Abstract] [Full Text] [Related]
7. Replication of the A7(74) strain of Semliki Forest virus is restricted in neurons. Fazakerley JK, Pathak S, Scallan M, Amor S, Dyson H. Virology; 1993 Aug; 195(2):627-37. PubMed ID: 8393239 [Abstract] [Full Text] [Related]
8. Semliki Forest virus infects mouse brain endothelial cells and causes blood-brain barrier damage. Soilu-Hänninen M, Erälinna JP, Hukkanen V, Röyttä M, Salmi AA, Salonen R. J Virol; 1994 Oct; 68(10):6291-8. PubMed ID: 7916058 [Abstract] [Full Text] [Related]
9. Following Acute Encephalitis, Semliki Forest Virus is Undetectable in the Brain by Infectivity Assays but Functional Virus RNA Capable of Generating Infectious Virus Persists for Life. Fragkoudis R, Dixon-Ballany CM, Zagrajek AK, Kedzierski L, Fazakerley JK. Viruses; 2018 May 18; 10(5):. PubMed ID: 29783708 [Abstract] [Full Text] [Related]
10. Role of immune responses in protection and pathogenesis during Semliki Forest virus encephalitis. Amor S, Scallan MF, Morris MM, Dyson H, Fazakerley JK. J Gen Virol; 1996 Feb 18; 77 ( Pt 2 )():281-91. PubMed ID: 8627232 [Abstract] [Full Text] [Related]
11. Infection of cultured murine brain cells by Semliki Forest virus: effects of interferon-alpha beta on viral replication, viral antigen display, major histocompatibility complex antigen display and lysis by cytotoxic T lymphocytes. Morris A, Tomkins PT, Maudsley DJ, Blackman M. J Gen Virol; 1987 Jan 18; 68 ( Pt 1)():99-106. PubMed ID: 3492589 [Abstract] [Full Text] [Related]
12. Neutralizing and non-neutralizing monoclonal antibodies to the E2 glycoprotein of Semliki Forest virus can protect mice from lethal encephalitis. Boere WA, Benaissa-Trouw BJ, Harmsen M, Kraaijeveld CA, Snippe H. J Gen Virol; 1983 Jun 18; 64 (Pt 6)():1405-8. PubMed ID: 6854274 [Abstract] [Full Text] [Related]
13. Blood-brain barrier breakdown and increased intercellular adhesion molecule (ICAM-1/CD54) expression after Semliki Forest (A7) virus infection facilitates the development of experimental allergic encephalomyelitis. Erälinna JP, Soilu-Hänninen M, Röyttä M, Hukkanen V, Salmi AA, Salonen R. J Neuroimmunol; 1996 May 18; 66(1-2):103-14. PubMed ID: 8964903 [Abstract] [Full Text] [Related]
14. Identification of distinct antigenic determinants on Semliki Forest virus by using monoclonal antibodies with different antiviral activities. Boere WA, Harmsen T, Vinjé J, Benaissa-Trouw BJ, Kraaijeveld CA, Snippe H. J Virol; 1984 Nov 18; 52(2):575-82. PubMed ID: 6208379 [Abstract] [Full Text] [Related]
15. Immunoelectron microscopical labelling of a glycolipid in the envelopes of brain cell-derived budding viruses, Semliki Forest, influenza and measles, using a monoclonal antibody directed chiefly against galactocerebroside resulting from Semliki Forest virus infection. Pathak S, Illavia SJ, Khalili-Shirazi A, Webb HE. J Neurol Sci; 1990 May 18; 96(2-3):293-302. PubMed ID: 2376758 [Abstract] [Full Text] [Related]
16. Production of defective interfering virus in the brains of mice by an avirulent, in contrast with a virulent, strain of Semliki forest virus. Woodward CG, Smith H. Br J Exp Pathol; 1975 Aug 18; 56(4):363-72. PubMed ID: 1174462 [Abstract] [Full Text] [Related]
17. Role of interferon-gamma and nitric oxide in the neuropathogenesis of avirulent Semliki Forest virus infection. Keogh B, Atkins GJ, Mills KH, Sheahan BJ. Neuropathol Appl Neurobiol; 2003 Dec 18; 29(6):553-62. PubMed ID: 14636162 [Abstract] [Full Text] [Related]
18. The role of complement in monoclonal antibody-mediated protection against virulent Semliki Forest virus. Boere WA, Benaissa-Trouw BJ, Harmsen T, Erich T, Kraaijeveld CA, Snippe H. Immunology; 1986 Aug 18; 58(4):553-9. PubMed ID: 3015781 [Abstract] [Full Text] [Related]
19. Identification of linear epitopes on Semliki Forest virus E2 membrane protein and their effectiveness as a synthetic peptide vaccine. Snijders A, Benaissa-Trouw BJ, Oosterlaken TA, Puijk WC, Posthumus WP, Meloen RH, Boere WA, Oosting JD, Kraaijeveld CA, Snippe H. J Gen Virol; 1991 Mar 18; 72 ( Pt 3)():557-65. PubMed ID: 1706409 [Abstract] [Full Text] [Related]